866-997-4948(US-Canada Toll Free)

Europe Prostate Cancer Drugs Market Report 2016

Published By :

QYResearch

Published Date : Sep 2016

Category :

Cancer

No. of Pages : 121 Pages

Notes:

Sales, means the sales volume of Prostate Cancer Drugs

Revenue, means the sales value of Prostate Cancer Drugs



This report studies sales (consumption) of Prostate Cancer Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Abbvie

Astra Zeneca

Janssen Pharmaceuticals

Sanofi

Amgen

Astellas Pharma

Bayer

BMS

Dendreon

Endo Pharmaceuticals

Ferring Pharmaceutical



Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Prostate Cancer Drugs in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux



Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by application, this report focuses on sales, market share and growth rate of Prostate Cancer Drugs in each application, can be divided into

Application 1

Application 2

Application 3



Table of Contents



Europe Prostate Cancer Drugs Market Report 2016

1 Prostate Cancer Drugs Overview

1.1 Product Overview and Scope of Prostate Cancer Drugs

1.2 Classification of Prostate Cancer Drugs

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Prostate Cancer Drugs

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Prostate Cancer Drugs Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Prostate Cancer Drugs (2011-2021)

1.5.1 Europe Prostate Cancer Drugs Sales and Growth Rate (2011-2021)

1.5.2 Europe Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)



2 Europe Prostate Cancer Drugs by Manufacturers, Type and Application

2.1 Europe Prostate Cancer Drugs Market Competition by Manufacturers

2.1.1 Europe Prostate Cancer Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Prostate Cancer Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Prostate Cancer Drugs (Volume and Value) by Type

2.2.1 Europe Prostate Cancer Drugs Sales and Market Share by Type (2011-2016)

2.2.2 Europe Prostate Cancer Drugs Revenue and Market Share by Type (2011-2016)

2.3 Europe Prostate Cancer Drugs (Volume and Value) by Countries

2.3.1 Europe Prostate Cancer Drugs Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Prostate Cancer Drugs Revenue and Market Share by Countries (2011-2016)

2.4 Europe Prostate Cancer Drugs (Volume) by Application



3 Germany Prostate Cancer Drugs (Volume, Value and Sales Price)

3.1 Germany Prostate Cancer Drugs Sales and Value (2011-2016)

3.1.1 Germany Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

3.1.2 Germany Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

3.1.3 Germany Prostate Cancer Drugs Sales Price Trend (2011-2016)

3.2 Germany Prostate Cancer Drugs Sales and Market Share by Manufacturers

3.3 Germany Prostate Cancer Drugs Sales and Market Share by Type

3.4 Germany Prostate Cancer Drugs Sales and Market Share by Application



4 France Prostate Cancer Drugs (Volume, Value and Sales Price)

4.1 France Prostate Cancer Drugs Sales and Value (2011-2016)

4.1.1 France Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

4.1.2 France Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

4.1.4 France Prostate Cancer Drugs Sales Price Trend (2011-2016)

4.2 France Prostate Cancer Drugs Sales and Market Share by Manufacturers

4.3 France Prostate Cancer Drugs Sales and Market Share by Type

4.4 France Prostate Cancer Drugs Sales and Market Share by Application



5 UK Prostate Cancer Drugs (Volume, Value and Sales Price)

5.1 UK Prostate Cancer Drugs Sales and Value (2011-2016)

5.1.1 UK Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

5.1.2 UK Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

5.1.5 UK Prostate Cancer Drugs Sales Price Trend (2011-2016)

5.2 UK Prostate Cancer Drugs Sales and Market Share by Manufacturers

5.3 UK Prostate Cancer Drugs Sales and Market Share by Type

5.4 UK Prostate Cancer Drugs Sales and Market Share by Application



6 Russia Prostate Cancer Drugs (Volume, Value and Sales Price)

6.1 Russia Prostate Cancer Drugs Sales and Value (2011-2016)

6.1.1 Russia Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

6.1.2 Russia Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

6.1.6 Russia Prostate Cancer Drugs Sales Price Trend (2011-2016)

6.2 Russia Prostate Cancer Drugs Sales and Market Share by Manufacturers

6.3 Russia Prostate Cancer Drugs Sales and Market Share by Type

6.4 Russia Prostate Cancer Drugs Sales and Market Share by Application



7 Italy Prostate Cancer Drugs (Volume, Value and Sales Price)

7.1 Italy Prostate Cancer Drugs Sales and Value (2011-2016)

7.1.1 Italy Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

7.1.2 Italy Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

7.1.7 Italy Prostate Cancer Drugs Sales Price Trend (2011-2016)

7.2 Italy Prostate Cancer Drugs Sales and Market Share by Manufacturers

7.3 Italy Prostate Cancer Drugs Sales and Market Share by Type

7.4 Italy Prostate Cancer Drugs Sales and Market Share by Application



8 Spain Prostate Cancer Drugs (Volume, Value and Sales Price)

8.1 Spain Prostate Cancer Drugs Sales and Value (2011-2016)

8.1.1 Spain Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

8.1.2 Spain Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

8.1.8 Spain Prostate Cancer Drugs Sales Price Trend (2011-2016)

8.2 Spain Prostate Cancer Drugs Sales and Market Share by Manufacturers

8.3 Spain Prostate Cancer Drugs Sales and Market Share by Type

8.4 Spain Prostate Cancer Drugs Sales and Market Share by Application



9 Benelux Prostate Cancer Drugs (Volume, Value and Sales Price)

9.1 Benelux Prostate Cancer Drugs Sales and Value (2011-2016)

9.1.1 Benelux Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

9.1.2 Benelux Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Prostate Cancer Drugs Sales Price Trend (2011-2016)

9.2 Benelux Prostate Cancer Drugs Sales and Market Share by Manufacturers

9.3 Benelux Prostate Cancer Drugs Sales and Market Share by Type

9.4 Benelux Prostate Cancer Drugs Sales and Market Share by Application



10 Europe Prostate Cancer Drugs Manufacturers Analysis

10.1 Abbvie

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Prostate Cancer Drugs Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Abbvie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 Astra Zeneca

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Prostate Cancer Drugs Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 Janssen Pharmaceuticals

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Prostate Cancer Drugs Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Sanofi

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Prostate Cancer Drugs Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Amgen

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Prostate Cancer Drugs Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Astellas Pharma

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Prostate Cancer Drugs Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Bayer

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Prostate Cancer Drugs Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 Bayer Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 BMS

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Prostate Cancer Drugs Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 BMS Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 Dendreon

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Prostate Cancer Drugs Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 Dendreon Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 Endo Pharmaceuticals

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Prostate Cancer Drugs Product Type, Application and Specification

10.10.2.1 Type I

10.10.2.2 Type II

10.10.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

10.11 Ferring Pharmaceutical



11 Prostate Cancer Drugs Manufacturing Cost Analysis

11.1 Prostate Cancer Drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Prostate Cancer Drugs



12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Prostate Cancer Drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015

12.4 Downstream Buyers



13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List



14 Europe Prostate Cancer Drugs Market Forecast (2016-2021)

14.1 Germany Prostate Cancer Drugs Sales Forecast (2016-2021)

14.2 France Prostate Cancer Drugs Sales Forecast (2016-2021)

14.3 UK Prostate Cancer Drugs Sales Forecast (2016-2021)

14.4 Russia Prostate Cancer Drugs Sales Forecast (2016-2021)

14.5 Italy Prostate Cancer Drugs Sales Forecast (2016-2021)

14.6 Spain Prostate Cancer Drugs Sales Forecast (2016-2021)

14.7 Benelux Prostate Cancer Drugs Sales Forecast (2016-2021)

14.8 Europe Prostate Cancer Drugs Sales Forecast by Type (2016-2021)

14.9 Europe Prostate Cancer Drugs Sales Forecast by Application (2016-2021)



15 Research Findings and Conclusion



16 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer





List of Table

List of Tables and Figures



Figure Picture of Prostate Cancer Drugs

Table Classification of Prostate Cancer Drugs

Figure Europe Sales Market Share of Prostate Cancer Drugs by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Prostate Cancer Drugs

Figure Europe Sales Market Share of Prostate Cancer Drugs by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)

Figure France Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)

Figure UK Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)

Figure Russia Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)

Figure Italy Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)

Figure Spain Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)

Figure Benelux Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)

Figure Europe Prostate Cancer Drugs Sales and Growth Rate (2011-2021)

Figure Europe Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)

Table Europe Prostate Cancer Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Prostate Cancer Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Prostate Cancer Drugs Sales Share by Manufacturers

Figure 2016 Prostate Cancer Drugs Sales Share by Manufacturers

Table Europe Prostate Cancer Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Prostate Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Prostate Cancer Drugs Revenue Share by Manufacturers

Table 2016 Europe Prostate Cancer Drugs Revenue Share by Manufacturers

Table Europe Prostate Cancer Drugs Sales and Market Share by Type (2011-2016)

Table Europe Prostate Cancer Drugs Sales Share by Type (2011-2016)

Figure Sales Market Share of Prostate Cancer Drugs by Type (2011-2016)

Figure Europe Prostate Cancer Drugs Sales Growth Rate by Type (2011-2016)

Table Europe Prostate Cancer Drugs Revenue and Market Share by Type (2011-2016)

Table Europe Prostate Cancer Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Prostate Cancer Drugs by Type (2011-2016)

Figure Europe Prostate Cancer Drugs Revenue Growth Rate by Type (2011-2016)

Table Europe Prostate Cancer Drugs Sales and Market Share by Countries (2011-2016)

Table Europe Prostate Cancer Drugs Sales Share by Countries (2011-2016)

Figure Sales Market Share of Prostate Cancer Drugs by Countries (2011-2016)

Table Europe Prostate Cancer Drugs Revenue and Market Share by Countries (2011-2016)

Table Europe Prostate Cancer Drugs Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Prostate Cancer Drugs by Countries (2011-2016)

Table Europe Prostate Cancer Drugs Sales and Market Share by Application (2011-2016)

Table Europe Prostate Cancer Drugs Sales Share by Application (2011-2016)

Figure Sales Market Share of Prostate Cancer Drugs by Application (2011-2016)

Figure Germany Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

Figure Germany Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

Figure Germany Prostate Cancer Drugs Sales Price Trend (2011-2016)

Table Germany Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Prostate Cancer Drugs Sales by Type (2015 and 2016)

Table Germany Prostate Cancer Drugs Market Share by Type (2015 and 2016)

Table Germany Prostate Cancer Drugs Sales by Application (2015 and 2016)

Table Germany Prostate Cancer Drugs Market Share by Application (2015 and 2016)

Figure France Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

Figure France Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

Figure France Prostate Cancer Drugs Sales Price Trend (2011-2016)

Table France Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)

Table France Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)

Table France Prostate Cancer Drugs Sales by Type (2015 and 2016)

Table France Prostate Cancer Drugs Market Share by Type (2015 and 2016)

Table France Prostate Cancer Drugs Sales by Application (2015 and 2016)

Table France Prostate Cancer Drugs Market Share by Application (2015 and 2016)

Figure UK Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

Figure UK Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

Figure UK Prostate Cancer Drugs Sales Price Trend (2011-2016)

Table UK Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)

Table UK Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Prostate Cancer Drugs Sales by Type (2015 and 2016)

Table UK Prostate Cancer Drugs Market Share by Type (2015 and 2016)

Table UK Prostate Cancer Drugs Sales by Application (2015 and 2016)

Table UK Prostate Cancer Drugs Market Share by Application (2015 and 2016)

Figure Russia Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

Figure Russia Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

Figure Russia Prostate Cancer Drugs Sales Price Trend (2011-2016)

Table Russia Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Prostate Cancer Drugs Sales by Type (2015 and 2016)

Table Russia Prostate Cancer Drugs Market Share by Type (2015 and 2016)

Table Russia Prostate Cancer Drugs Sales by Application (2015 and 2016)

Table Russia Prostate Cancer Drugs Market Share by Application (2015 and 2016)

Figure Italy Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

Figure Italy Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

Figure Italy Prostate Cancer Drugs Sales Price Trend (2011-2016)

Table Italy Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Prostate Cancer Drugs Sales by Type (2015 and 2016)

Table Italy Prostate Cancer Drugs Market Share by Type (2015 and 2016)

Table Italy Prostate Cancer Drugs Sales by Application (2015 and 2016)

Table Italy Prostate Cancer Drugs Market Share by Application (2015 and 2016)

Figure Spain Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

Figure Spain Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

Figure Spain Prostate Cancer Drugs Sales Price Trend (2011-2016)

Table Spain Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Prostate Cancer Drugs Sales by Type (2015 and 2016)

Table Spain Prostate Cancer Drugs Market Share by Type (2015 and 2016)

Table Spain Prostate Cancer Drugs Sales by Application (2015 and 2016)

Table Spain Prostate Cancer Drugs Market Share by Application (2015 and 2016)

Figure Benelux Prostate Cancer Drugs Sales and Growth Rate (2011-2016)

Figure Benelux Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)

Figure Benelux Prostate Cancer Drugs Sales Price Trend (2011-2016)

Table Benelux Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)

Table Benelux Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)

Table Benelux Prostate Cancer Drugs Sales by Type (2015 and 2016)

Table Benelux Prostate Cancer Drugs Market Share by Type (2015 and 2016)

Table Benelux Prostate Cancer Drugs Sales by Application (2015 and 2016)

Table Benelux Prostate Cancer Drugs Market Share by Application (2015 and 2016)

Table Prostate Cancer Drugs Basic Information List

Table Abbvie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Abbvie Prostate Cancer Drugs Sales Market Share (2011-2016)

Table Astra Zeneca Basic Information List

Table Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Astra Zeneca Prostate Cancer Drugs Sales Market Share (2011-2016)

Table Janssen Pharmaceuticals Basic Information List

Table Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Janssen Pharmaceuticals Prostate Cancer Drugs Sales Market Share (2011-2016)

Table Sanofi Basic Information List

Table Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi Prostate Cancer Drugs Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Prostate Cancer Drugs Sales Market Share (2011-2016)

Table Astellas Pharma Basic Information List

Table Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Astellas Pharma Prostate Cancer Drugs Sales Market Share (2011-2016)

Table Bayer Basic Information List

Table Bayer Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer Prostate Cancer Drugs Sales Market Share (2011-2016)

Table BMS Basic Information List

Table BMS Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table BMS Prostate Cancer Drugs Sales Market Share (2011-2016)

Table Dendreon Basic Information List

Table Dendreon Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dendreon Prostate Cancer Drugs Sales Market Share (2011-2016)

Table Endo Pharmaceuticals Basic Information List

Table Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Endo Pharmaceuticals Prostate Cancer Drugs Sales Market Share (2011-2016)

Table Ferring Pharmaceutical Basic Information List

Table Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ferring Pharmaceutical Prostate Cancer Drugs Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Prostate Cancer Drugs

Figure Manufacturing Process Analysis of Prostate Cancer Drugs

Figure Prostate Cancer Drugs Industrial Chain Analysis

Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015

Table Major Buyers of Prostate Cancer Drugs

Table Distributors/Traders List

Figure Germany Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Germany Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure France Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)

Figure France Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure UK Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)

Figure UK Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Russia Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Italy Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Spain Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)

Table Europe Prostate Cancer Drugs Sales Forecast by Type (2016-2021)

Table Europe Prostate Cancer Drugs Sales Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *